Gene Therapy Using Hepatocyte Growth Factor Expressing Adenovirus Improves Skin Flap Survival in a Rat Model
Journal of Korean Medical Science
; : S228-S236, 2014.
Article
в En
| WPRIM
| ID: wpr-191056
Ответственная библиотека:
WPRO
ABSTRACT
Hepatocyte growth factor (HGF) is a potent angiogenic factor that can stimulate the production of blood vessels in ischemic tissue. We investigated whether gene therapy using HGF-expressing adenovirus could enhance skin flap survival. Sprague-Dawley rats were randomly divided into three groups. Rats were subdermally injected with HGF-expressing adenovirus (HGF virus group), recombinant HGF (rhHGF group), or phosphate buffered saline (PBS group) 2 days before and immediately after 3 x 9 cm caudal flap elevation. The survival area of the skin flap, the ratio of blood flow, CD31-positive vessels and, VEGF expression were examined. Skin flap viability was significantly increased in the HGF virus group compared to the rhHGF and PBS groups (71.4% +/- 5.9%, 63.8%+/- 6.4%, and 39.2% +/- 13.0%, respectively) (P = 0.025). Furthermore, the blood flow ratio was significantly increased in the HGF virus group. In the HGF virus group, the number of CD31-positive vessels and vascular endothelial growth factor (VEGF) expression were significantly increased. Gene therapy using HGF-expressing adenovirus increase VEGF expression, the number of viable capillaries, and blood flow to the flap, thereby improving skin flap survival.
Key words
Полный текст:
1
База данных:
WPRIM
Основная тема:
Surgical Flaps
/
Genetic Therapy
/
Random Allocation
/
Adenoviridae
/
Skin Transplantation
/
Rats, Sprague-Dawley
/
Hepatocyte Growth Factor
/
Neovascularization, Physiologic
/
Plastic Surgery Procedures
/
Models, Animal
Тип исследования:
Prognostic_studies
Пределы темы:
Animals
Язык:
En
Журнал:
Journal of Korean Medical Science
Год:
2014
Тип:
Article